Whilst increased urination is not listed as an adverse effect in the Summary of Product Characteristics, some patients report changes in urinary frequency when starting treatment
Article: My Peptide Protocol at 43: BPC-157, Tesamorelin, NAD+, and What Actually Changed My Peptide Protocol at 43: BPC-157, Tesamorelin, NAD+, and What Actually Changed I'm going to walk you through exactly what I take, why I take it, and what shifted in my body composition, recovery, and daily performance after integrating peptides into a system I'd already spent two decades building
The answer, in almost every scenario, is that early dosing is preferable to missing a dose
It requires a clinician who knows your case and is reachable when something is off, which is a large part of what ongoing care is for
This step is critical, and getting it wrong can degrade the peptide and invalidate your research
Today, they show up in places many would never have anticipated: in grocery baskets, on beverage aisles, in fashion stock rooms, and in strategic planning decks for global brands